granted
on 26 Jan 2024
Last Applicant/ Owned by
51 Sleeper Street, Suite 800
Boston
MA
02210
Serial Number
97668318 filed on 08th Nov 2022
Registration Number
N/A
Correspondent Address
Marie Lavalleye
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
"THERAPEUTICS"
Providing medical and scientific research information in the fields of pharmaceuticals, clinical trials, cancer, and auto-immune diseases; Development of molecules for use by others in developing and designing pharmaceutical products and preparations for the treatment of cancer and auto-immune diseases "THERAPEUTICS" Pharmaceutical products and preparations for the treatment of cancer and auto-iRead More
Providing medical and scientific research information in the fields of pharmaceuticals, clinical trials, cancer, and auto-immune diseases; Development of molecules for use by others in developing and designing pharmaceutical products and preparations for the treatment of cancer and auto-immune diseases
Pharmaceutical products and preparations for the treatment of cancer and auto-immune diseases; Molecules used as a component in pharmaceutical preparations for the treatment of cancer and auto-immune diseases
No 97668318
No Service Mark
No 044399.00018
No
No
No
No
No
No
No
No
| Status Date | Action Taken |
|---|---|
| 30th Jan 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 26th Jan 2024 | SOU TEAS EXTENSION RECEIVED |
| 26th Jan 2024 | SOU EXTENSION 1 FILED |
| 26th Jan 2024 | SOU EXTENSION 1 GRANTED |
| 19th Dec 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| 24th Oct 2023 | PUBLISHED FOR OPPOSITION |
| 24th Oct 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 04th Oct 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 18th Sep 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 15th Sep 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
